JUDO BIO
Live / Applied — First extension granted (statement of use) (as of 13 Feb 2026)
What this means for you
Not registered yet, but its 14 Aug 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98697738
- Mark type
- Stylized text
- Filed
- 14 Aug 2024
- Published for opposition
- 24 Jun 2025
- Attorney of record
- Holly A. Coldiron
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical and therapeutic agents for the treatment of nephrological and systemic diseases, namely, inborn errors of metabolism, gout, hypertension, type 2 diabetes, chronic heart failure, nephrolithiasis, and endocrine disorders; Pharmaceutical preparations, namely, oligonucleotides, siRNA and antisense RNA (asRNA) for medical use and use in the treatment of nephrological and systemic diseases, namely, inborn errors of metabolism, gout, hypertension, type 2 diabetes, chronic heart failure, nephrolithiasis, and endocrine disorders
Owner
- Judo Bio, Inc., Cambridge, MA, US
- Judo Bio, Inc., Cambridge, MA, US
Prosecution history
- 14 Feb 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Feb 2026 — SOU EXTENSION 1 GRANTED
- 13 Feb 2026 — SOU EXTENSION 1 FILED
- 13 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 19 Aug 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 24 Jun 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 24 Jun 2025 — PUBLISHED FOR OPPOSITION
- 18 Jun 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 20 May 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 16 May 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 16 May 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 16 May 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 26 Feb 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 26 Feb 2025 — NON-FINAL ACTION E-MAILED
- 26 Feb 2025 — NON-FINAL ACTION WRITTEN